Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
BIPH
Upturn stock ratingUpturn stock rating

Safeplus International Holdings Limited (BIPH)

Upturn stock ratingUpturn stock rating
$16.33
Last Close (24-hour delay)
Profit since last BUY0.31%
upturn advisory
Consider higher Upturn Star rating
BUY since 6 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

06/27/2025: BIPH (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

0 Analysts rated it

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Year Target Price $

Year Target Price $

Analyst’s Price TargetsFor last 52 week
$Target price
Low$15.1
Current$16.33
high$19.68

Analysis of Past Performance

Type Stock
Historic Profit -7.81%
Avg. Invested days 46
Today’s Advisory Consider higher Upturn Star rating
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 3.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 06/27/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 0.36M USD
Price to earnings Ratio -
1Y Target Price -
Price to earnings Ratio -
1Y Target Price -
Volume (30-day avg) -
Beta 1.04
52 Weeks Range 15.10 - 19.68
Updated Date 06/23/2025
52 Weeks Range 15.10 - 19.68
Updated Date 06/23/2025
Dividends yield (FY) 7.69%
Basic EPS (TTM) -0.09

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -547.85%

Management Effectiveness

Return on Assets (TTM) -15.02%
Return on Equity (TTM) -

Valuation

Trailing PE -
Forward PE -
Enterprise Value -
Price to Sales(TTM) 0.96
Enterprise Value -
Price to Sales(TTM) 0.96
Enterprise Value to Revenue 0.53
Enterprise Value to EBITDA -
Shares Outstanding -
Shares Floating -
Shares Outstanding -
Shares Floating -
Percent Insiders -
Percent Institutions -

Analyst Ratings

Rating -
Target Price -
Buy -
Strong Buy -
Buy -
Strong Buy -
Hold -
Sell -
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

Safeplus International Holdings Limited

stock logo

Company Overview

overview logo History and Background

I am unable to find enough information to provide a company history and background for Safeplus International Holdings Limited. Further research is needed

business area logo Core Business Areas

leadership logo Leadership and Structure

I am unable to find enough information to provide a Leadership and structure for Safeplus International Holdings Limited. Further research is needed

Top Products and Market Share

overview logo Key Offerings

Market Dynamics

industry overview logo Industry Overview

I am unable to find enough information to provide an industry overview for Safeplus International Holdings Limited. Further research is needed

Positioning

I am unable to find enough information to provide market postioning for Safeplus International Holdings Limited. Further research is needed

Total Addressable Market (TAM)

I am unable to find enough information to provide total market value or Safeplus International Holdings Limited positioning. Further research is needed

Upturn SWOT Analysis

Strengths

  • Limited Data - No Strengths

Weaknesses

  • Limited public information
  • Lack of detailed financial data

Opportunities

  • Further research required to identify opportunities

Threats

  • Limited visibility in market
  • Inability to accurately assess competitive pressures

Competitors and Market Share

competitor logo Key Competitors

Competitive Landscape

Cannot determine without competitor information or overall market data.

Growth Trajectory and Initiatives

Historical Growth: Insufficient data available to calculate or provide any financial information

Future Projections: Insufficient data available to calculate or provide any financial information

Recent Initiatives: Insufficient data available to calculate or provide any financial information

Summary

Due to limited publicly available information, a comprehensive analysis of Safeplus International Holdings Limited cannot be completed. Further in-depth research is needed to gather the necessary data and context to assess the company's performance, market position, and future prospects. Without sufficient data, a definitive conclusion on the company's strengths, weaknesses, opportunities, and threats cannot be determined.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Publicly available news sources.
  • Company filings (if available).

Disclaimers:

This analysis is based on limited publicly available information and should not be considered financial advice. The lack of data impacts the accuracy of this analysis.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Safeplus International Holdings Limited

Exchange NYSE
Headquaters -
IPO Launch date 1999-11-26
CEO -
Sector Healthcare
Industry Medical Instruments & Supplies
Full time employees 2
Full time employees 2

Biophan Technologies, Inc. develops and markets various technologies for the medical device industries. The company is seeking partners to monetize its patented technologies, including biothermal power supply and pulsewidth modulation technology to enhance the performance of pacemakers and neurostimulators, and photonics and nanomaterials patents. The company was founded in 1963 and is based in Pittsford, New York.